Position in BMY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$52,952
-$2,300 QoQ
Shares Held
919
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,319
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roble, Belko & Company, Inc holds $3,192,754 across 12 Drug Manufacturers - General names. BMY ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,506 | $1,385,529 | |
| 2 | JNJ |
Johnson & Johnson
|
3,549 | $901,339 | |
| 3 | LLY |
ELI LILLY & Co
|
416 | $498,962 | |
| 4 | PFE |
Pfizer Inc
|
8,245 | $198,539 | |
| 5 | MRK |
Merck & Co., Inc.
|
478 | $61,423 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
919 | $52,952 | |
| 7 | GSK |
GSK plc
|
685 | $35,907 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
218 | $27,542 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,952 | 919 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $55,252 | 911 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $48,707 | 903 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $35,809 | 794 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $36,291 | 784 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $47,328 | 776 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,656 | 100 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $5,174 | 100 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,153 | 100 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,423 | 100 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $5,131 | 100 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,804 | 100 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $6,395 | 100 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,931 | 100 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $18,707 | 260 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $18,483 | 260 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,020 | 260 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $37,245 | 510 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $16,211 | 260 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $15,384 | 260 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $17,440 | 261 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $16,476 | 261 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $16,189 | 261 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $15,735 | 261 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $32,986 | 561 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $17,335 | 311 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||